Tools created in Mayo Clinic's Neurobiology of Parkinson's Disease and Related Disorders aid rapid screening of compound libraries for chemicals targeting oligomeric stage of fibrillization.

A new clinical trial to treat Parkinson’s disease will start in Perth next year using a drug currently being tested as a ...

BioArctic AB (publ) (NASDAQ Stockholm: BIOA B) announced today that the interim safety review of the clinical Phase 2a study EXIST showed exidavnemab to be safe and well-tolerated, whereby the second ...

Discover how Parkinson's disease begins in the gut, not the brain. Learn the early digestive warning signs that appear years ...

Parkinson’s disease affects more than 10 million people worldwide. Discover its causes, symptoms, and the latest innovations ...

Stem cells can fight disease from the inside out. But spas and clinics are selling treatments that are unproven, expensive, ...

You can increase dopamine action by eating protein-rich foods, exercising, and meditating. Learn more about natural ways to improve mood and motivation.

Demonstrated greater a-synuclein reductions compared to other gene therapy approaches ...

Only a handful of stem cell therapies are currently approved by the F.D.A., mainly for treating blood cancer and immune ...

The U.S. health secretary said people should have access to experimental therapies including unregulated uses of stem cells.